← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
In Vitro Strategies, Llc
Flemington, NJ
$313,204
Total funding
2
Grants
Funding over time
peak $64K · FY2011–21$100K$75K$50K$25K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$313,204 · 2
By mechanism
N01$200,200 · 1
N02$113,004 · 1
Investigators at In Vitro Strategies, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
NIH DRUG DEVELOPMENT CONSULTING SERVICES$64,004
N02 · FY2013 · NS
IN VITRO STRATEGIES LIMITED LIABILITY COMPANY:1198212 [16-014035]IGF::CL::IGF$44,000
N01 · FY2017 · DA
IN VITRO STRATEGIES LIMITED LIABILITY COMPANY:1198212 [16-014035]IGF::CL::IGF$44,000
N01 · FY2016 · DA
IN VITRO STRATEGIES LIMITED LIABILITY COMPANY:1198212 [16-014035]IGF::CL::IGF$35,700
N01 · FY2019 · DA
NIH DRUG DEVELOPMENT CONSULTING SERVICES$34,000
N02 · FY2012 · NS
IN VITRO STRATEGIES LIMITED LIABILITY COMPANY:1198212 [16-014035]IGF::CL::IGF$34,000
N01 · FY2020 · DA
IN VITRO STRATEGIES LIMITED LIABILITY COMPANY:1198212 [16-014035]IGF::CL::IGF$25,500
N01 · FY2021 · DA
IN VITRO STRATEGIES LIMITED LIABILITY COMPANY:1198212 [16-014035]IGF::CL::IGF$17,000
N01 · FY2018 · DA
NIH DRUG DEVELOPMENT CONSULTING SERVICES$15,000
N02 · FY2011 · NS